Literature DB >> 16237638

Polymorphisms of the Toll-like receptors and human disease.

David A Schwartz1, Donald N Cook.   

Abstract

The Toll-like receptor (TLR) family regulates both innate and adaptive immune responses. Given its broad effect on immunity, the function of TLRs in various human diseases has been investigated largely by comparing the incidence of disease among persons with different polymorphisms in the genes that participate in TLR signaling. These studies demonstrate that TLR function affects several diseases, including sepsis, immunodeficiencies, atherosclerosis, and asthma. These findings have resulted in new opportunities to study the pathogenesis of disease, identify subpopulations at greater risk of disease, and, potentially, identify novel therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16237638     DOI: 10.1086/431985

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  24 in total

Review 1.  Herpesviral infection and Toll-like receptor 2.

Authors:  Ming-sheng Cai; Mei-li Li; Chun-fu Zheng
Journal:  Protein Cell       Date:  2012-08-04       Impact factor: 14.870

Review 2.  Targeting Toll-like receptors: emerging therapeutics?

Authors:  Elizabeth J Hennessy; Andrew E Parker; Luke A J O'Neill
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

3.  Time course of endotoxin-induced airways' inflammation in healthy subjects.

Authors:  Virginie Doyen; Zaina Kassengera; Duc Huy Phong Dinh; Olivier Michel
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

4.  Homozygosity for the toll-like receptor 2 R753Q single-nucleotide polymorphism is a risk factor for cytomegalovirus disease after liver transplantation.

Authors:  Seung H Kang; Rima C Abdel-Massih; Robert A Brown; Ross A Dierkhising; Walter K Kremers; Raymund R Razonable
Journal:  J Infect Dis       Date:  2012-01-04       Impact factor: 5.226

5.  The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells.

Authors:  Maria Shatz; Daniel Menendez; Michael A Resnick
Journal:  Cancer Res       Date:  2012-06-06       Impact factor: 12.701

Review 6.  Identifying novel spatiotemporal regulators of innate immunity.

Authors:  Francisco Victorino; Scott Alper
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

7.  The R753Q polymorphism abrogates toll-like receptor 2 signaling in response to human cytomegalovirus.

Authors:  Robert A Brown; Jonathon H Gralewski; Raymund R Razonable
Journal:  Clin Infect Dis       Date:  2009-11-01       Impact factor: 9.079

8.  SNP-set analysis replicates acute lung injury genetic risk factors.

Authors:  Nuala J Meyer; Zhongyin John Daye; Melanie Rushefski; Richard Aplenc; Paul N Lanken; Michael G S Shashaty; Jason D Christie; Rui Feng
Journal:  BMC Med Genet       Date:  2012-06-28       Impact factor: 2.103

9.  Role of TLR4/NADPH oxidase/ROS-activated p38 MAPK in VCAM-1 expression induced by lipopolysaccharide in human renal mesangial cells.

Authors:  I-Ta Lee; Ruey-Horng Shih; Chih-Chung Lin; Jung-Tsan Chen; Chuen-Mao Yang
Journal:  Cell Commun Signal       Date:  2012-11-15       Impact factor: 5.712

10.  Role of the functional Toll-Like receptor-9 promoter polymorphism (-1237T/C) in increased risk of end-stage renal disease: a case-control study.

Authors:  Hsin-Yi Yang; Kuo-Cheng Lu; Herng-Sheng Lee; Shih-Ming Huang; Yuh-Feng Lin; Chia-Chao Wu; Donald M Salter; Sui-Lung Su
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.